Back
bluebird bio Vs. Perspective Therapeutics Industry Stock Comparison
Sell
12
BLUE
bluebird bio
Last Price:
0.30
Seasonality Move:
5.31%
Sell
30
CATX
Perspective Therapeutics
Last Price:
2.99
Seasonality Move:
34.33%
Sell
12
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
- The current bluebird bio [BLUE] share price is $0.30. The Score for BLUE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- BLUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $0.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLUE is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
BLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 22.6 | Sell |
Chaikin Money Flow: | -1310235 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.36 - 0.5) | Sell |
Bollinger Bands (100): | (0.4 - 0.98) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.83 | Sell |
Relative Strength Index (14 RSI): | 9.64 | Sell |
Chaikin Money Flow: | -11653674 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.08 - 12.98) | Sell |
Bollinger Bands (100): | (10.5 - 14.68) | Sell |
BLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.34 | Sell |
20-day SMA: | 0.41 | Sell |
50-day SMA: | 0.47 | Sell |
200-day SMA: | 0.9 | Sell |
8-day EMA: | 0.33 | Sell |
20-day EMA: | 0.39 | Sell |
50-day EMA: | 0.48 | Sell |
200-day EMA: | 1.07 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.54 | Sell |
20-day SMA: | 10.1 | Sell |
50-day SMA: | 11.82 | Sell |
200-day SMA: | 12.75 | Sell |
8-day EMA: | 7.04 | Sell |
20-day EMA: | 9.29 | Sell |
50-day EMA: | 11.19 | Sell |
200-day EMA: | 11.43 | Sell |
bluebird bio Earnings Growth & BLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.66 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
bluebird bio Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |